Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04542057
Status:
COMPLETED
Last Update Posted:
2023-10-16
First Post:
2020-09-01
Brief Title:
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Sponsor:
Verona Pharma plc
Organization:
Verona Pharma plc
Organization Data
Organization:
Verona Pharma plc
Class:
INDUSTRY
Study ID:
RPL554-CO-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Verona Pharma plc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Iqvia Pty Ltd | INDUSTRY |